Page 153 - Recognizing axial spondyloarthritis - Janneke de Winter
P. 153

REFERENCES
1. Berg R Van Den, Gaalen F Van, Helm-Van Mil A Van Der, Huizinga T, Heijde D Van Der. Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden early arthritis cohort. Ann Rheum Dis 2012;71:1366–1369.
2. Cheung PP, Tymms KE, Wilson BJ, Shadbolt B, Brook AS, Dorai Raj AK, et al. Infliximab in severe active ankylosing spondylitis with spinal ankylosis. Intern Med J 2008;38:396– 401.
3. Tomero E, Mulero J, Miguel E de, Fernández-Espartero C, Gobbo M, Descalzo M a, et al. Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme. Rheumatology (Oxford) 2014;53:353–60.
4. Haglund E, Bremander AB, Petersson IF, Strömbeck B, Bergman S, Jacobsson LTH, et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis 2011;70:943–948.
5. Paramarta JE, Rycke L De, Heijda TF, Ambarus C a, Vos K, Dinant HJ, et al. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis. Ann Rheum Dis 2013;72:1793–9.
6. Baraliakos X, Listing J, Rudwaleit M, Brandt J, Sieper J, Braun J. Radiographic progression in
patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor alpha antibody infliximab. Ann Rheum Dis 2005;64:1462–1466.
7. Baeten D, Breban M, Lories R, Schett G, Sieper J. Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum 2013;65:12–20.
8. Rudwaleit M, Khan MA, Sieper J. Commentary: The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria? Arthritis Rheum 2005;52:1000–1008.
9. Said-Nahal R, Miceli-Richard C, Berthelot JM, Duché A, Dernis- Labous E, Blévec G Le, et al. The familial form of spondylarthropathy: A clinical study of 115 multiplex families. Arthritis Rheum 2000;43:1356–1365.
10. Said-Nahal R, Miceli-Richard C, D’Agostino MA, Dernis- Labous E, Berthelot JM, Duche A, et al. Phenotypic diversity is not determined by independent genetic factors in familial spondylarthropathy. Arthritis Rheum 2001;45:478–484.
11. Rahman P, Inman RD, Gladman DD, Reeve JP, Peddle L, Maksymowych WP. Association of interleukin-23 receptor variants with ankylosing spondylitis. Arthritis Rheum 2008;58:1020–5.
12. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A, et al. Association scan of 14,500
GENERAL DISCUSSION AND SUMMARY
151
 NINE


















































































   151   152   153   154   155